Patent Assignment
Reel/Frame 029803/0373
Assignment of Assignor's Interest
Recorded: 2013-02-13
Pages: 7
Assignors
LIU, SHUANG
Executed: 2013-01-09
DUFFY, BRYAN CORDELL
Executed: 2013-01-09
JIANG, MAY XIAOWU
Executed: 2013-01-09
WANG, RUIFANG
Executed: 2013-01-11
QUINN, JOHN FREDERICK
Executed: 2013-01-09
MARTIN, GREGORY SCOTT
Executed: 2013-01-09
ZHAO, HE
Executed: 2013-01-09
MOLINO, BRUCE FRANCIS
Executed: 2013-01-09
YOUNG, PETER RONALD
Executed: 2013-01-17
Assignee
RESVERLOGIX CORP.
202,279 MIDPARK WAY SE, CALGARY, AB, T2X 1M2, CANADA
Covered Property
(1)
Novel Heterocyclic Compounds as Bromodomain Inhibitors
Application:
61/745,274 →
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 8, 2013
From: RESVERLOGIX CORP.
To: RVX THERAPEUTICS INC.
Reel/Frame 029948/0434 →
General Conveyance and Assumption Agreement
Jul 14, 2014
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENETICS CORP.
Reel/Frame 033312/0422 →
Change of Name
Dec 21, 2016
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 041120/0548 →
Assignment of Assignor's Interest
Dec 23, 2016
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 041182/0891 →